Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
10.1002/med.21599 52 ColemanM
The values are given in Table 8 and Figure 4
In addition to its diabetes management benefits, Semaglutide GLP-1 has garnered attention for its potential in weight management
Constipation and diarrhea as well as bowel incontinence can be indicators of pelvic floor dysfunction and thus these types of drugs could exacerbate these existing symptoms
The qualifications for semaglutide include having a BMI of 30 or higher, or a BMI of 27 or higher who also have weight-related health conditions like hypertension, type 2 diabetes, or high cholesterol
Patients who stop these medications should work closely with their healthcare provider to monitor weight, blood glucose, and other metabolic parameters
